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ABSTRACT
Objective: The problems of breast mass, pain, or discharge are extremely common in the Iraqi population, as well as, globally. However, the trend in 
most health-care institutions is that most breast lesions are of benign biologic behavior and among true neoplastic lesions. Marital status has been 
linked to the outcome of breast malignancy; however, the link is controversial.Thus, the aim of the present study is to make a clear insight into the true 
incidence rate of carcinoma and their risk factors.
Materials and Methods: The study was designed to be a cross-sectional study involving a cohort of 182 Iraqi women with the breast mass. Patients 
were selected in a systemic random way from the population of patients already visiting the surgical consultation clinic and ward and oncology unit 
in Al-Dewaniyah teaching hospital in Al-Diwaniyah province, Iraq.
Result: The present study showed that the most breast lesions (82%) were benign, and the most frequent one was a fibroadenoma (37.4%). Malignant 
lesions accounted for a small percentage (17.4%). Mean age of patients with carcinoma was 49.78±7.58 years and most all cases occurred after 
20 years of age and that 87.5% of cases were seen after the age of 40. Majority of breast carcinoma were of invasive ductal carcinoma. No significant 
association was seen between the clinical behavior of breast mass and marital status; however, malignant clinical behavior showed significant 
association with age.
Conclusion: The incidence rate of malignant breast lesions in Iraqi women with breast mass is similar to that seen worldwide and that age is the main 
risk factor that predicts the malignant clinical behavior of a breast mass.
Keywords: Breast cancer, Marital status, Iraq.
INTRODUCTION
In daily clinical practice, the problems of breast mass, pain, or discharge 
is extremely common in the Iraqi population, as well as, globally [1]. 
Nearly all patients develop fear about the possibility of malignancy 
when they acquire a breast mass. However, the trend in most health-
care institutions is that most breast lesions are of benign biologic 
behavior, and among true neoplastic lesions, the rate of malignancy 
is somewhat low [2]. The most common form of malignant breast 
lesions is of epithelial origin, namely carcinoma. The risk of developing 
breast carcinoma has a positive correlation with age, being rare 
before the age of 25, the incidence rate becoming increasing greater 
after 25, and majority of cases are diagnosed after the age of 50; the 
median age at diagnosis is around 65 years old [3]. Unfortunately, a 
substantial amount of data suggested that Iraqi women showed the 
younger age of acquiring breast cancer and that the rate of breast 
carcinoma during the past two decades outnumbered that of the 
preceding decades. The increasing incidence has been linked by many 
authors to the first, second, and third Arab Gulf Wars, during which the 
exposure to chemical weapons and radiation-based weapons is blamed 
to be number one risk factor [4]. For most surgeons, the histological 
report of a breast mass is the main step in making the decision about 
the nature of breast mass. From histological point of view, benign 
breast lesions can be inflammatory such as breast abscess and duct 
ectasia, proliferative, such as fibrocystic disease and fibroadenoma, 
and reactive conditions such as fat necrosis; whereas most malignant 
lesions are epithelial in origin, ductal carcinoma is the most frequent 
and accounts for approximately 80% of the cases. Lobular carcinoma 
comes next and accounts for <20% of the cases [5]. Both ductal 
carcinoma and lobular carcinoma can be infiltrative or non-infiltrative 
lesions [6]. In addition to advancing age, other risk factors are blamed 
to participate in the causation of breast carcinoma, including hormonal 
imbalance, especially excess estrogen exposure, obesity, alcohol intake, 
lack of exercise, women who got married late and depends on exclusive 
bottle feeding are also at higher risk, exposure to chemical agents and 
radiation, and the list of risk factors includes several other controversial 
suggestions [7]. The present study was designed to be a cross-sectional 
study that included a cohort of Iraqi women with various breast lesions 
to make a clear insight about the true incidence rate of carcinoma 
and risk factors associated with the development of malignant breast 
lesions.
PATIENTS AND METHODS
The study was designed to be a cross-sectional study involving a cohort 
of 182 Iraqi women with the breast mass. Patients were selected in a 
systemic random way from the population of patients already visiting 
the surgical consultation clinic and ward and oncology unit in Al-
Dewaniyah teaching hospital in Al-Diwaniyah province/Iraq. The 
beginning of data collection was dated the 20th January 2018 and ended 
on 10th June 2018. The questionnaire form was based on the following:
•	 Sociodemographic characteristics of patients: Mainly age and marital 
status.
•	 Review	of	histopathological	 features	 including	histological	 type,	
biological behavior (benign vs. malignant), grade, and stage of 
malignant tumors.
Data were collected, summarized, analyzed, and presented using two 
software	 programs;	 these	 were	 the	 Statistical	 Package	 for	 the	 Social	
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were presented as mean, standard deviation, and range, whereas categorical 
variables were expressed as number and percentage. The incidence rate of 
depression was expressed as a percentage. Association between categorical 
variables	 was	 assessed	 using	 either	 Chi-square	 test	 or	 Yates	 correction	




This study included 182 cases of breast lesions in women with an age 
range of 16–72 years and a mean age of 38.79±12.74 years. Taking 
marital status into consideration, 150 (82.4%), whereas, 32 (17.6%) 
were unmarried. The breast lesion was situated on the right side in 
85 (46.7%), in the left side in 76 (41.8%), and bilateral in 21 (11.5%). 
According to clinical behavior, 150 (82.4%) had benign lesions and 
32 (17.6%) had malignant lesions, as shown in Table 1.
Of	182	patients,	68	had	fibroadenoma	constituting	37.4%	of	all	samples	
included in the present study and 45.3% of benign cases enrolled in 
the current study. 21 had fibrocystic disease constituting 11.5% of 
all sample included in the present study and 14.0% of benign cases 
enrolled in the current study. 44 had inflammatory lesions in the form 
of mastitis, duct ectasia, and abscess forming 24.2% of all samples 
included in the present study and 29.3% of benign cases enrolled in 
the	current	study.	Seventeen	cases	had	simple	cyst	accounting	for	9.3%	
of all samples included in the present study and 11.3% of benign cases 
enrolled in the current study, as shown in Table	2.	Of	182	patients,	3	had	
carcinoma in situ constituting 1.6% of all sample included in the present 
study and 9.4% of malignant cases enrolled in the current study. 24 had 
invasive ductal carcinoma constituting 13.2% of all sample included in 
the present study and 75.0% of malignant cases enrolled in the current 
study. Four had invasive lobular carcinoma forming 2.2% of all sample 
included in the present study and 12.5% of malignant cases enrolled 
in	the	current	study.	One	case	had	medullary	carcinoma	accounting	for	
0.5% of all sample included in the present study and 3.1% of malignant 
cases enrolled in the current study, as shown in Table 3.
With respect to the grade of malignant lesions, 6 patients had Grade I 
breast cancer accounting for 18.8% of all malignant cases included 
in this study, 19 had Grade II breast cancer constituting 59.4% of 
all malignant cases enrolled in the current study, and 7 patients had 
Grade III breast cancer forming 21.9% of all malignant cases subjected 




The following study showed that patients with malignant lesions were 
significantly older than patients with benign lesions, 49.78±7.58 years 
versus 36.66±12.4 years (p<0.001), as shown in Fig. 3. The distribution 
Table 1: General characteristics of the study sample
Characteristic Value
Number of cases 182
Age
Mean±SD	(years) 38.79±12.74
Range (Min.-Max.) (years) 56 (16–72)
Marital status, n (%)
Married, n (%) 150 (82.4)
Unmarried, n (%) 32 (17.6)
Site
Right, n (%) 85 (46.7)
Left, n (%) 76 (41.8)
Bilateral, n (%) 21 (11.5)
Clinical	behavior
Benign, n (%) 150 (82.4)
Malignant, n (%) 32 (17.6)
SD:	Standard	deviation;	Min.:	minimum;	Max.:	maximum;	n:	number	of	cases
Table 2: The frequency distribution and rates of benign breast 
lesions




Fibroadenoma 68 37.4 45.3
Fibrocystic disease 21 11.5 14.0
Inflammatory
(mastitis, duct ectasia, 
and abscess)
44 24.2 29.3
Simple	cyst 17 9.3 11.3
Total 150 82.4 100.0
n: number of cases
Fig. 3: The difference in mean age between patients with benign 
breast lesions and patients with malignant breast lesions
Fig. 1: The distribution of malignant cases according to grade
Fig. 2: The distribution of malignant cases according to stage
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of malignant and benign lesions according to 20 years’ intervals is 
shown in Table 4. There was no significant association between age of 
patients and type of malignancy (p=0.779), [Table 5]. In addition, there 
was no significant association between the age of patients and grade of 
the malignant tumor (p=0.842), [Table 6].
Moreover, there was no significant association between the age of 
patients and stage of the malignant tumor (p=0.871), [Table 7]. There 
was no significant association between marital status and clinical 
behavior of breast lesions (p=0.064). In addition, there was no 
significant association between marital status and type of benign lesions 
(p=0.176). Added to that, there was no significant association between 
marital status and type of malignant lesion (p=0.871). Moreover, there 
was no significant association between grade and stage of malignancy 
and the marital status of patients (p=0.584 and 0.837, respectively), as 
shown in Table 8.
DISCUSSION
The present study showed that the most breast lesions (82%) were 
benign and that, among benign lesions, the most frequent one was 
the fibroadenoma (37.4%). Malignant lesions accounted for a small 
percentage (17.4%). Mean age of patients with carcinoma was 
49.78±7.58 years and most all cases occurred after 20 years of age and 
that 87.5% of cases were seen after the age of 40. Majority of breast 
carcinoma	were	of	invasive	ductal	carcinoma,	of	Grade	II	and	Stage	II.	
No significant association was seen between the clinical behavior of a 
breast mass and marital status; however, malignant clinical behavior 
showed significant association with age. In addition, we found no 
association between grade and stage of breast cancer and marital 
status of women, suggesting that marital status has nothing to do with 
the prognosis of breast cancer. These results disagree with the finding 
of Hinyard et al., who stated that prognosis is worse in unmarried 
than married women with breast cancer [8]. A growing body of 
evidence shows that mortality following a cancer diagnosis is higher 
in unmarried than married patients [9-12]. However, studies on the 
association specific to breast cancer are limited [13,14]. Two main 
pathways have been proposed to explain the benefits of marital status 
on cancer and overall longevity: Better economic resources and greater 
social support [15]. However, these two factors need to be investigated 
in our community. In one large sample study, the percentage of women 
who reported symptoms (of total screened) increased clearly by the age 
of the women, 21.8% in age group of 50–54 years and 30% in age group 
of 65–69 years, respectively [16].
Primary breast cancer is the most common cancer afflicting women 
(incidence of 1/8–10), and it is the second leading cause of cancer death 
overall (following lung cancer) [17]. Breast cancer which is detected 
early is curable, but it has a 10–20% chance of distant metastases 
occurring even 10–20 years after the initial diagnosis [18]. The most 
common sites of breast cancer metastasis are the bone, lungs, and 
liver [19]. Worldwide, breast cancer comprises 10.4% of all cancer 
Table 5: Association between age and type of malignant breast lesion
Malignant lesion 21–40 years 41–60 years >60 years Total Mean age±SD p
CIS 0 3 0 3 47.33±4.04 0.779 †
Not significantInvasive ductal carcinoma 4 19 1 24 50.04±8.49
Invasive lobular carcinoma 0 4 0 4 50.75±4.35
Medullary carcinoma 0 1 0 1 47.00±
Total 4 27 1 32 49.78±7.58
† Kruskal–Wallis test
Table 6: Association between age and grade of malignant breast lesion
Grade 21–40 years 41–60 years >60 years Total Mean age±SD p
I 0 6 0 6 51.50±5.47 0.842†
Not significantII 2 16 1 19 49.79±6.89
III 2 5 0 7 48.29±11.12
Total 4 27 1 32 49.78±7.58
† Kruskal–Wallis test
Table 7: Association between age and stage of malignant breast lesion
Stage 21–40 years 41–60 years >60 years Total Mean age±SD P
0 0 3 0 3 47.33±4.04 0.827 †
Not significantI 0 5 0 5 50.80±3.70
II 2 12 1 15 49.13±8.64
III 2 5 0 7 49.29±8.98
IV 0 2 0 2 57.50±3.54
Total 4 27 1 32 49.78±7.58
† Kruskal–Wallis test
Table 3: The frequency distribution and rates of malignant 
breast lesions




CIS 3 1.6 9.4
Invasive ductal carcinoma 24 13.2 75.0
Invasive lobular carcinoma 4 2.2 12.5
Medullary carcinoma 1 0.5 3.1
Total 32 17.6 100.0
CIS:	carcinoma	in situ, n: number of cases
Table 4: Association between the clinical behavior of breast 








≤20 15 (10.0) 0 (0.0) 33.095 <0.001
highly 
significant
21–40 82 (54.7) 4 (12.5)
41–60 45 (30.0) 27 (84.4)
>60 8 (5.3) 1 (3.1)
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incidences among women, making it the second most common type 
of non-skin cancer (after lung cancer) and the fifth most common 
cause of cancer death. In 2004, breast cancer caused 519,000 deaths 
worldwide (7% of cancer deaths; almost 1% of all deaths) [20]. Lack 
of effect of marital status on the incidence rate of breast cancer should 
open the door to search for other important environmental hazards 
associated with breast cancer such as radiation in the Iraqi community. 
There is known to be a slight increase in risk in ladies who work with 
low doses of radiation over a long period of time, for example, X-ray 
technicians [21-23].
In conclusion, the present study showed that the incidence rate of 
malignant breast lesions in Iraqi women with breast mass is similar to 
that seen worldwide and that age is the main risk factor that predicts 
the malignant clinical behavior of a breast mass. No association was 
reported between marital status and biologic behavior of breast 
mass, suggesting that other possible environmental factors need to be 
disclosed as risk factors for breast cancer in Iraqi women in addition 
to age.
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